19.6: Key Words and Terms
- Page ID
- 16539
\( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)
anaphase | G2 phase | mTOR signaling |
apoptosis | Guardian of the Genome | necrosis |
ATM kinase | immunotherapy | oncogenic viruses |
benign tumors | intergrin | p14ARF |
cancer cells | interphase | p21 |
CDKs | invasive tumors | p53 |
cell cycle | LFS | |
cell cycle checkpoints | Li-Fraumeni Syndrome | PD-L1 |
chemotherapy | M checkpoint | programmed cell death |
Chk2 | M phase of the cell cycle | prophase |
colchicine | malignant tumors | protein phosphorlyation |
cyclin | MAPK | proteasome |
cyclin level in cell cycle | maturation | radiation therapy |
cytokinesis | maturation promoting | S phase |
dideoxyNTP | Mdm2 | signal transduction |
elephant p53 genes | metaphase | SV40 |
FAK | metastasis | T antigens |
G0 of the cell cycle | mitosis | taxol |
G1 checkpoint | mitosis promoting factor | telophase |
G1 phase | mitotic phases | tumor suppressor protein |
G2 checkpoint | MPF | ubiquitination |